ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.60
0.71%
US Tech 100
19,636.04
0.55%
S&P 500
5,770.20
0.55%
US Dollar vs CAD
1.43715
0.00%
Bitcoin
86,004.82
-0.17%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Leap Therapeutics Inc (LPTX) Share Price

Leap Therapeutics Inc

Leap Therapeutics Inc (LPTX)

NASDAQ
0.4392
-0.0011
(-0.25%)
Closed March 08 3:00PM
Delayed by 15 minutes
0.427
-0.0122
(-2.78%)
After Hours: 5:53PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.427
Bid
0.425
Ask
0.4877
Volume
210,043
0.4274 Day's Range 0.4525
0.3999 52 Week Range 4.79
Market Cap
16.362M
Previous Close
0.4403
Open
0.4335
Last Trade
183
@
0.427
(formt)
Last Trade Time
Financial Volume
US$ 91,974
VWAP
0.437883
Average Volume (3m)
802,088
Shares Outstanding
38,317,897
Dividend Yield
-
PE Ratio
-0.21
Earnings Per Share (EPS)
-2.12
Revenue
-
Net Profit
-81.41M

About Leap Therapeutics Inc

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib... Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.leaptx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Leap Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LPTX. The last closing price for Leap Therapeutics was US$0.44. Over the last year, Leap Therapeutics shares have traded in a share price range of US$ 0.3999 to US$ 4.79.

Leap Therapeutics currently has 38,317,897 shares outstanding. The market capitalization of Leap Therapeutics is US$16.87 million. Leap Therapeutics has a price to earnings ratio (PE ratio) of -0.21.

Ask ADVFN Intelligence (AI)

LPTX Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
January 28 2025
LPTX (-0.25%)

Form 8-K - Current report
Edgar (US Regulatory)
November 13 2024
LPTX (-0.25%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 13 2024
LPTX (-0.25%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
November 06 2024
LPTX (-0.25%)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Edgar (US Regulatory)
October 31 2024
LPTX (-0.25%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.033-7.173913043480.460.46990.39993049370.43696678CS
4-0.0705-14.17085427140.49750.56990.39994983850.49820461CS
12-2.653-86.13636363643.083.580.39998020881.12896993CS
26-2.403-84.91166077742.834.790.39995412231.83039058CS
52-1.943-81.98312236292.374.790.39993731482.08434796CS
156-17.173-97.573863636417.619.50.39995135546.51984309CS
260-23.873-98.242798353924.341.70.399991438618.62254843CS

LPTX - Frequently Asked Questions (FAQ)

What is the current Leap Therapeutics share price?
The current share price of Leap Therapeutics is US$ 0.427
How many Leap Therapeutics shares are in issue?
Leap Therapeutics has 38,317,897 shares in issue
What is the market cap of Leap Therapeutics?
The market capitalisation of Leap Therapeutics is USD 16.87M
What is the 1 year trading range for Leap Therapeutics share price?
Leap Therapeutics has traded in the range of US$ 0.3999 to US$ 4.79 during the past year
What is the PE ratio of Leap Therapeutics?
The price to earnings ratio of Leap Therapeutics is -0.21
What is the reporting currency for Leap Therapeutics?
Leap Therapeutics reports financial results in USD
What is the latest annual profit for Leap Therapeutics?
The latest annual profit of Leap Therapeutics is USD -81.41M
What is the registered address of Leap Therapeutics?
The registered address for Leap Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Leap Therapeutics website address?
The website address for Leap Therapeutics is www.leaptx.com
Which industry sector does Leap Therapeutics operate in?
Leap Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.14M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.92M
KZIAKazia Therapeutics Ltd
US$ 1.1899
(40.80%)
4.5M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
570.43k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.54M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.13M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
332.1k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
143.04M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
142.23M

LPTX Discussion

View Posts
Monksdream Monksdream 1 month ago
LPTX, new 52/low
👍️0
glenn1919 glenn1919 1 month ago
LPTX.......................................................bottomplay.......................................https://stockcharts.com/h-sc/ui?s=lptx&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 1 month ago
.50s seems good for an entry after the brutal dump in some .54 
👍️0
Deano361 Deano361 1 month ago
Bad day today but when this gets the data results and they go to market on the drug, this is an easy 10x stock.
👍️0
ANTADOG ANTADOG 2 months ago
nice volume comin' in, 3,22~~, ANT
👍️0
ANTADOG ANTADOG 2 months ago
added some more, only partial fill, ANT
👍️0
ANTADOG ANTADOG 2 months ago
nice chart setup, solid 3,50 break gettin' closer, ANT
👍️0
ANTADOG ANTADOG 2 months ago
4's towards nxt update and jp conference almost a given, ANT
👍️0
ANTADOG ANTADOG 2 months ago
touchin' 3's again, so little vol needed, nxt update should be saweet imvho ANT
👍️0
ANTADOG ANTADOG 2 months ago
touched 3 again, small prelude of things to come, imosho ANT
👍️0
ANTADOG ANTADOG 3 months ago
hearin' some good things comin' our way, hmm, u got to pay to play, ANT
👍️0
ANTADOG ANTADOG 3 months ago
Added 2,96~~ ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,40~~ because they know... ANT
👍️0
ANTADOG ANTADOG 3 months ago
accumulated a nice amount around 3 bucks, longterm, ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,35~~ ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,33~~ ANT
👍️0
ANTADOG ANTADOG 3 months ago
Volume intact, ANT
👍️0
ANTADOG ANTADOG 3 months ago
hooverin' above 3 bucks, ceo certainly gave them somethin' to think about, to be continued.... ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,33~~ ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,24~~ ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,19~~ ANT
👍️0
ANTADOG ANTADOG 3 months ago
mm in trouble lol, ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,12~~ ANT
👍️0
ANTADOG ANTADOG 3 months ago
3,10 break is close, hmm, ANT
👍️0
ANTADOG ANTADOG 3 months ago
added some 2,80's, likin' the chart, ANT
👍️0
glenn1919 glenn1919 3 months ago
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
ANTADOG ANTADOG 4 months ago
And some more 3,25's longterm, ANT
👍️0
ANTADOG ANTADOG 4 months ago
added 3,70 ANT
👍️0
ANTADOG ANTADOG 4 months ago
held first support, startin' to like this one more and more, gild support, fyi ANT
👍️0
ANTADOG ANTADOG 4 months ago
added first support, ANT
👍️0
ANTADOG ANTADOG 4 months ago
consistent buyin' often means deeper pockets like what they see or are about to find out, so they add while it's cheap, imo but we'll see soon, ANT
👍️0
ANTADOG ANTADOG 4 months ago
puppy's goin' for a new 52wk high imo ANT
👍️0
ANTADOG ANTADOG 4 months ago
because it's a double digitland stock, xcellent results will propel it imosho ANT
👍️0
joelawyer joelawyer 4 months ago
Any clue what's driving this major upside move the last week?

👍️0
glenn1919 glenn1919 4 months ago
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 months ago
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 months ago
LPTX under $3
👍️0
Monksdream Monksdream 8 months ago
LPTX under $3
👍️0
Monksdream Monksdream 8 months ago
LPTX under $2
👍️0
Monksdream Monksdream 10 months ago
LPTX under $5
👍️0
glenn1919 glenn1919 11 months ago
LPTX...................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 months ago
LPTX 10Q due March 12
👍️0
glenn1919 glenn1919 1 year ago
LPTX.......................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
LPTX................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
LPTX new 52 week low
👍️0
Monksdream Monksdream 1 year ago
LPTX new 52 week low
👍️0
Slicky1315 Slicky1315 2 years ago
Wow..almost a year and no one posted anything!!
👍️0
VivaLasVegas VivaLasVegas 3 years ago
No one in their right mind gives 2 Sheets what some joke analyst gives for any price target

They are Shills
👍️0
stockguard stockguard 3 years ago
LPTX Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update Jan. 23
Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Leap Therapeutics (LPTX) to $6 from $5 and keeps an Overweight rating on the shares. Following the ASCO GI update for DKN-01, Leap hosted a conference call on Friday to walk through the data and lay out potential next steps, the analyst notes. When considering potential treatment effect, Catanzaro thinks the signal in DKK1-high patients looks even more compelling. Leap believes it could initiate a small randomized Phase II as part of the current IND that could generate data in 2023, while simultaneously engaging regulatory agencies on registrational strategies. Most notably, BeiGene's (BGNE) opt-in decision for Asian rights will almost certainly be a 2022 event, and the analyst continues to believe the ASCO GI update should make that a straightforward choice.
👍️0
Deano361 Deano361 3 years ago
yep, something big happening here.
👍️0

Your Recent History

NASDAQ
LPTX
Leap Therapeutics
FX
CHFTWD
CHF vs TWD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads